Zum Hauptinhalt springen

international

12. Februar 2023 | international

Providing Low-barrier Addiction Treatment Via a Telemedicine Consultation Service During the COVID-19 Pandemic in Los Angeles, County: An Assessment 1 Year Later.

Providing Low-barrier Addiction Treatment Via a Telemedicine Consultation Service During the COVID-19 Pandemic in Los Angeles, County: An Assessment 1 Year Later. Kennedy AJ, George JS, Rossetti G, Brown CO, Ragins K, Dadiomov D, Trotzky-Sirr…

07. Februar 2023 | international

Impact of COVID-19-related regulatory changes on nationwide access to buprenorphine: An interrupted time series design.

Impact of COVID-19-related regulatory changes on nationwide access to buprenorphine: An interrupted time series design. Roy PJ, Kim KC, Suda K, Luo J, Wang X, Olejniczak D, Liebschutz JM. Drug Alcohol Depend Rep. 2023 Mar;6:100135. doi…

31. Januar 2023 | international

Telemedicine Use and Quality of Opioid Use Disorder Treatment in the US During the COVID-19 Pandemic.

Telemedicine Use and Quality of Opioid Use Disorder Treatment in the US During the COVID-19 Pandemic. Hailu R, Mehrotra A, Huskamp HA, Busch AB, Barnett ML. JAMA Netw Open. 2023;6(1):e2252381. doi:10.1001/jamanetworkopen.2022.5238…

31. Januar 2023 | international

Perceptions of COVID-19 risk during the pandemic: perspectives from people seeking medication for opioid use disorder.

Perceptions of COVID-19 risk during the pandemic: perspectives from people seeking medication for opioid use disorder. Clingan SE, Cousins SJ, Lin C, Nguyen TE, Hser YI, Mooney LJ. Ann Med. 2023 Dec;55(1):480-489. doi: 10.1080/07853890…

20. Januar 2023 | international

Discontinuation of Buprenorphine Treatment for Opioid Use Disorder During the Coronavirus Disease-2019 Pandemic: A Multilevel Framework.

Discontinuation of Buprenorphine Treatment for Opioid Use Disorder During the Coronavirus Disease-2019 Pandemic: A Multilevel Framework. Saloner B, Chang HY, Alexander GC, Stein BD. Med Care. 2023 Feb 1;61(2):95-101. doi: 10.1097/MLR.0…

09. Januar 2023 | international

Buprenorphine Treatment Episodes During the First Year of COVID: a Retrospective Examination of Treatment Initiation and Retention.

Buprenorphine Treatment Episodes During the First Year of COVID: a Retrospective Examination of Treatment Initiation and Retention. Stein BD, Landis RK, Sheng F, Saloner B, Gordon AJ, Sorbero M, Dick AW. J Gen Intern Med. 2022 Dec 6:1–…

06. Januar 2023 | international

Effect of Didactic Training on Barriers and Biases to Treatment of Opioid Use Disorder: Meeting the Ongoing Needs of Patients with Opioid Use Disorder in the Emergency Department during the COVID-19 Pandemic.

Effect of Didactic Training on Barriers and Biases to Treatment of Opioid Use Disorder: Meeting the Ongoing Needs of Patients with Opioid Use Disorder in the Emergency Department during the COVID-19 Pandemic. Johnson E, Bolshakova M, Vosooghi…

Weitere
akutelle Informationen
zu den Themengebieten